Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Summit Therapeutics Inc (NASDAQ: SMMT) closed at $23.52 in the last session, up 6.43% from day before closing price of $22.10. In other words, the price has increased by $6.43 from its previous closing price. On the day, 4.44 million shares were traded. SMMT stock price reached its highest trading level at $24.21 during the session, while it also had its lowest trading level at $22.38.
Ratios:
We take a closer look at SMMT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.31 and its Current Ratio is at 8.31. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on January 08, 2025, initiated with a Buy rating and assigned the stock a target price of $35.
On December 11, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $30.
On December 06, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $31.Jefferies initiated its Buy rating on December 06, 2024, with a $31 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 27 ’24 when Zanganeh Mahkam bought 54,321 shares for $3.72 per share. The transaction valued at 201,874 led to the insider holds 24,923,800 shares of the business.
Zanganeh Mahkam bought 30,000 shares of SMMT for $112,500 on Mar 26 ’24. The Chief Executive Officer now owns 30,000 shares after completing the transaction at $3.75 per share. On Mar 27 ’24, another insider, Zanganeh Mahkam, who serves as the Chief Executive Officer of the company, bought 26,000 shares for $3.72 each. As a result, the insider paid 96,720 and bolstered with 520,814 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SMMT now has a Market Capitalization of 17344778240 and an Enterprise Value of 16890382336.
Stock Price History:
The Beta on a monthly basis for SMMT is -0.88, which has changed by 3.857143 over the last 52 weeks, in comparison to a change of 0.24359846 over the same period for the S&P500. Over the past 52 weeks, SMMT has reached a high of $33.89, while it has fallen to a 52-week low of $2.10. The 50-Day Moving Average of the stock is 25.07%, while the 200-Day Moving Average is calculated to be 73.88%.
Shares Statistics:
According to the various share statistics, SMMT traded on average about 2.16M shares per day over the past 3-months and 2709940 shares per day over the past 10 days. A total of 737.09M shares are outstanding, with a floating share count of 114.59M. Insiders hold about 84.45% of the company’s shares, while institutions hold 11.50% stake in the company. Shares short for SMMT as of 1735603200 were 19939807 with a Short Ratio of 9.22, compared to 1732838400 on 16840640. Therefore, it implies a Short% of Shares Outstanding of 19939807 and a Short% of Float of 16.780001.
